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Introduction
Protein destruction may seem like a strange way
for a cell to control its growth. The entire process
by which cells multiply is based on synthesis-
the duplication of almost every molecule in the
cell. If protein synthesis is one of the foundations
of growth, then why are so many proteins de-
stroyed as one cell becomes two?
The answer to this question is control. The
process of cell duplication is, of course, more
complicated than simply replicating the cellular
contents and dividing. Survival of all eukaryotic
cells depends on their ability to regulate how and
when they grow. To persist, cells must multiply
only in response to specific signals, they must
have mechanisms to detect errors in the dupli-
cation process, and they must establish a defined
sequence for the events of duplication, so that
DNA replication, for example, always precedes
cell division. In addition to synthesis, therefore,
an important part of growth is maintaining tight
control over all of the proteins needed to make a
new cell. Protein destruction-proteolysis-
plays a pivotal role in controlling the activity of
these proteins.
Proteolysis is particularly suited to control-
ling the events of cell duplication because it is a
swift, direct, and irreversible way to limit the
activity of a protein. When a protein is destroyed
by proteolysis, its levels in the cell can drop in-
stantly and dramatically. Through this property,
milestones in the duplication process are defined,
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such as exit from mitosis. Moreover, once a pro-
tein is destroyed, the only way it can reappear is
by new synthesis; this gives direction to the
events of cell duplication, and ensures that these
events fire in the proper sequence.
As any newcomer to the field can appreciate,
the regulation of eukaryotic cell growth is a com-
plex phenomenon. How and when a cell grows is
ultimately the product of interactions among
vast groups of transcription factors, kinases,
phosphatases, and other regulatory molecules.
Similarly, the ways in which these molecules are
affected by proteolysis are also complex. There
are many different substrate proteins, a diverse
and complicated proteolytic machinery, and a
variety of mechanisms that modulate interac-
tions between the two. Despite this complexity,
however, the fundamental ways in which prote-
olysis works are surprisingly simple: nature has
made the most of just a handful of strategies. In
this review, I discuss how these simple strategies
for using and controlling the power of proteolysis
dominate many aspects of eukaryotic cell
growth.
Proteolysis and Growth Control
To understand the simple ways in which cells put
proteolysis to work to control their growth, the
story needs to get a little complicated. We need
to understand how cells structure the events re-
quired for their duplication, and how proteolysis
works. We also need to understand how these
two areas intersect and how the destruction of
particular proteins relates to growth control.
Once these more complicated issues have been
discussed, the simple themes behind the function
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Fig. 1. The cell cycle. The diagram shows a sche-
matic of the eukaryotic cell cycle. Shown are the
five stages of the cell cycle, the key events that occur
within each stage, and the key regulatory molecules
involved. See text for details.
of proteolysis in growth control will come into
focus.
Controlling Growth Through the Cell Cycle
How does one eukaryotic cell become two? In all
eukaryotic cells, the process of duplication occurs
within the context of a cell cycle-an ordered
series of events through which each cell must
pass in order to replicate. In the cell cycle, thou-
sands of biochemical reactions are corralled into
distinct groups that proceed in an ordered se-
quence. Each group of reactions in turn defines a
distinct stage of cell cycle progression. Because
passage from one stage of the cell cycle to the
next occurs in response to specific signals, such
as those generated by the presence of growth
factors, the existence of the cell cycle allows cells
to maintain tight control over their growth.
A simplified view of the cell cycle, with the
five stages of cell cycle progression, is shown in
Figure 1. In absence of growth factors, cells do
not cycle and are said to be quiescent, or in the
Go phase. In the presence of growth factors, cells
enter the cell cycle at the stage known as G1, and
prepare for duplication of their DNA. Late in G1,
and in response to specific signals from the en-
vironment, cells commit to undergoing an entire
cell cycle. After this commitment is made, cells
then enter S phase, during which time DNA
replication occurs, followed by another phase of
growth and reorganization, known as G2. If no
Protein detudcon
Fig. 2. Ubiquitin-mediated proteolysis. The dia-
gram depicts the four classes of enzymes involved in
transferring ubiquitin to target proteins. Note that
the E1-E4 nomenclature is generic and that there
are, for example, multiple E2 and E3 activities that
are usually composed of many subunits. See text for
details.
errors in the replication process are detected,
cells then enter the last stage of the cell cycle;
mitosis, or M phase-the point at which dupli-
cated chromosomes are neatly segregated into
two daughter cells.
At its simplest level, the cell cycle is con-
trolled by periodic fluctuations in the abundance
of proteins known as cyclins. Each stage of cell
cycle progression is defined by the expression of
particular cyclins that control stage-specific
events by activating particular kinases. For ex-
ample, human cyclin DI is expressed only in the
G1 phase of the cell cycle (see ref. 1 for review).
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The presence of cyclin D 1 activates cyclin-depen-
dent kinases (CDKs) 4 and 6, which in turn
phosphorylate the retinoblastoma protein Rb.
Phosphorylation of Rb liberates active E2F, a
transcription factor that activates (among other
things) the expression of genes required for DNA
synthesis (2). Because cyclin Dl expression is
limited to a narrow window of time within G1,
these E2F-activated genes are expressed only
when their products are needed, during the up-
coming S phase, and not at other stages in the
cell cycle. Similar regulatory cascades are initi-
ated at other points by other cyclins.
Although cyclins characterize each stage of
the cell cycle, they alone do not govern cell cycle
progression, for cyclins themselves are regulated.
Their synthesis is tightly controlled by the action
of transcription factors, and their activity is
tightly controlled by the action of regulatory pro-
teins (e.g., CDK inhibitors, which mask the ac-
tivity of cyclin-CDK complexes; reviewed in ref.
3). Moreover, cyclins work by signaling to ap-
propriate subsets of effector molecules: transcrip-
tion factors, regulators of DNA replication, and
factors required for specific events in the cell
cycle, like sister chromatid separation. In addi-
tion to cyclins, therefore, there are many mole-
cules that have an impact on cell cycle progres-
sion, and there are thus many molecules whose
activity must be precisely regulated for normal
cell cycle progression to occur. As discussed be-
low, proteolysis plays an important role in regu-
lating the activity of these molecules.
Before ending this brief review of the cell
cycle, it is worth noting that, although the details
may vary from one species to the next, the same
basic strategy for organizing and executing the
events of cell duplication is used by all eu-
karyotes. Indeed, the fundamental conservation
of this process in yeast to frogs to humans has
been instrumental to our understanding of how
and why cells cycle, and the role that proteolysis
plays in this process.
The Ubiquitin-Proteasome Pathway of Protein
Destruction
Cells can destroy proteins in many different
ways. A typical budding yeast cell, for example,
has well over 20 proteases at its disposal. Despite
this battery of different proteolytic activities,
however, one process-ubiquitin (Ub) -mediated
proteolysis-dominates the control of cell
growth. Almost all of the unstable proteins that
regulate eukaryotic cell growth are destroyed by
this unique pathway of protein breakdown.
Ub-mediated proteolysis is a process in
which proteins are first tagged by covalent link-
age to Ub,-a small, highly conserved protein-
and then destroyed by the proteasome-a large,
multicatalytic protease complex (for reviews see
refs. 4 and 5). A general scheme for the Ub-
proteasome pathway is shown in Figure 2. The
process begins when Ub forms a thioester bond
with a Ub-activating enzyme, or El. Ub is then
transferred to a Ub-conjugating enzyme, or E2.
The E2, either alone or in conjunction with a
Ub-protein ligase (E3), recognizes a specific ele-
ment in the target protein called a degron (4).
Once the degron has been recognized, Ub is
transferred to a lysine residue somewhere on the
target protein. Repeated rounds of this process
[perhaps catalyzed by a Ub-chain assembly fac-
tor, E4 (6)] results in a highly ubiquitylated tar-
get protein that is destroyed by the proteasome.
There are three reasons why Ub-mediated
proteolysis features prominently in the regula-
tion of cell cycle progression. First, Ub-mediated
proteolysis is highly selective. For a protein to be
destroyed by this pathway, it generally must
carry a degron to signal its ubiquitylation. This
selectivity means that, from within a collection
of regulatory molecules, specific proteins can be
singled out for destruction as needed. Second,
Ub-mediated proteolysis can destroy many pro-
teins. Multiple E2 and E3 complexes participate
in the pathway, each of which ubiquitylate a
distinct set of target proteins. This diversity al-
lows the Ub-proteasome pathway to destroy all
of the different proteins needed for coordinating
cell cycle progression. Finally, Ub-mediated pro-
teolysis can be precisely controlled. Interactions
between proteins and their respective E2/E3
complexes can be regulated, so that these pro-
teins are destroyed only in response to specific
signals. This control means that, even if a protein
contains a degron, it is not always unstable, but
rather can be destroyed at specific points in the
cell cycle. Together, these three unique attributes-
selectivity, diversity, and controllability-make
Ub-mediated proteolysis ideally suited to regulat-
ing complex events like cell cycle control.
Targets of Ubiquitin-Mediated Proteolysis
As a final approach to understanding how pro-
teolysis is used to control growth, we must iden-
tify the proteins that are targeted for destruction.
Table 1 shows a list of proteins that are involved
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Table 1. Cell cycle-related targets of ubiquitin-mediated proteolysis
Target Function Species E2/E3
Cell cycle kinases and their regulators
Cyclin DI G1 cyclin Hs SCF
Cyclin E G1 cydin Hs SCF
Clnl G1 cyclin Sc SCF
Cln2 G1 cyclin Sc SCF
Cln3 G1 cyclin Sc SCF
ClbS S-phase cyclin Sc APC
NIME Mitotic cyclin An APC
Clb2 Mitotic cyclin Sc APC
Clb3 Mitotic cyclin Sc APC
Cdcl 3 Mitotic cyclin Sp APC
Cyclin A Mitotic cyclin Ss APC
Cyclin BI Mitotic cyclin Xl APC
Cyclin B3 Mitotic cyclin Xl APC
p21 CDK inhibitor Hs SCF
p27 CDK inhibitor Hs Ubc2/Ubc3
Farl CDK inhibitor Sc SCF
Sicl CDK inhibitor Sc SCF
Swel CDK inhibitor Sc SCF
Ruml CDK inhibitor Sp SCF
NIMA Mitotic kinase An APC
Plkl Mitotic kinase Hs APC
Cdc5 Mitotic kinase/APC regulator Sc APC
Weel Mitotic inhibitory kinase Xl SCF
Cdc25 Mitotic phosphatase Sp Public
Regulators ofDNA replication
Cdc6 Replication initiation Sc SCF
Cdc18 Replication initiation Sp SCF
Geminin Replication inhibitor Xl APC
Factors required for mechanics of cell duplication and division
Pdsl Sister chromatid separation Sc APC
Cut2 Sister chromatid separation Sp APC
P58ctf 13 Kinetochore assembly Sc SCF
Ase 1 Mitotic spindle component Sp APC
Gicl Cytoskeletal rearrangement Sc SCF
Gic2 Cytoskeletal rearrangement Sc SCF
Regulators of transcription
DPI Transcription factor/E2F partner ?
E2F-1 Transcription factor Hs SCF
Fos Transcription factor Hs ?
Jun Transcription factor Hs ?
Myc Transcription factor Hs ?
p53 Transcription factor Hs ?
Mdm2 p53 antagonist Hs ?
Components of proteolytic machinery and their regulators
Cdc2O APC regulator Sc APC
Cdc4 SCF component Sc SCF
Grrl SCF component Sc SCF
CDK, cyclin-dependent kinase; Hs, Homo sapiens; Sc, Saccharomyces cerevisiae; An, Aspergillus nidulans; Sp, Schizosaccharomyces pombe;
Ss, Spisula solidissima; Xl, Xenopus laevis; SCF, Skp-Cullin-F-box complex; APC, anaphase-promoting complex.
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in the control of cell growth and that are de-
stroyed by Ub-mediated proteolysis. Table 1 also
lists, where known, the E2/E3 complexes that
ubiquitylate these proteins.
The first feature to emerge from Table 1 is
the diversity of growth-related proteins that are
destroyed by Ub-mediated proteolysis. There are
40-odd entries in Table 1, which together include
all of the major categories of proteins needed to
drive cell cycle progression. There are (i) cell
cycle kinases and their regulators, which the sig-
nal events require for cell duplication; (ii) regu-
lators of DNA replication, which maintain nor-
mal cell ploidy by limiting DNA replication to
once per cell cycle; (iii) factors required for the
mechanics of cell duplication, which drive the
structural rearrangements needed to produce a
daughter cell; (iv) regulators of transcription,
which carry out growth-regulated patterns of
gene synthesis; and (v) components of the pro-
teolytic machinery itself, which regulate all as-
pects of cell cycle progression. Confronted with
this list, it is difficult to imagine a type of growth-
related protein that is not represented here. The
number and breadth of these proteins illustrates
the importance of Ub-mediated proteolysis to
almost all aspects of eukaryotic growth control.
The second feature to emerge from Table 1 is
that most of these proteins are ubiquitylated by
one of two types of E2/E3 complexes; either an
anaphase promoting complex (APC) (7) or a
Skp-Cullin-F-box (SCF) complex (8). Detailed
discussion of the architecture, function, and reg-
ulation of APC and SCF complexes is beyond the
scope of this review (see refs. 9 and 10 for re-
views on the APC and SCF complexes, respec-
tively). But some features are worth considering
here. First, the APC and SCF are large, multisub-
unit complexes. Some forms of the APC, for ex-
ample, contain well over a dozen proteins, with
a predicted molecular weight of 750,000 kD (see
ref. 9 for a list of APC subunits). The intricate
nature of these complexes implies that their ac-
tivity is tightly regulated, because many gene
products must be present in the right place and at
the right time for an active APC or SCF complex
to assemble. Second, APC and SCF exist in mul-
tiple forms (1 1). Subtle variations in APC or SCF
subunit composition can create complexes that
either ubiquitylate different target proteins or
respond to different regulatory signals. There is
thus no one APC or SCF, but a rather a collection
of these activities, the members of which per-
form specialized tasks. Finally, although APC and
SCF are evolutionarily related complexes (12)
that have the same enzymatic activity (i.e., pro-
tein ubiquitylation), they tend to differ in the
types of proteins they ubiquitylate. The APC is
activated at the metaphase-to-anaphase transi-
tion, and thus plays a predominant role in de-
stroying proteins that regulate exit from mitosis.
SCF activity, in contrast, appears to be directed
more toward proteins involved in the Gl-to-S
transition-proteins such as the G1 cyclins [e.g.,
Cln2p in Saccharomyces cerevisiae (8)] and their
inhibitors [e.g., the human cyclin-dependent ki-
nase inhibitor p27 (13)]. Thus these two types of
ubiquitylation machines have evolved to carry
out distinct functions in the regulation of cell
growth.
A final point to be made from Table 1 is the
broad range of species represented. Indeed, it is
fair to say that probably all eukaryotes use Ub-
mediated proteolysis to control the-r growth.
Across the broad spectrum of eukaryotic life,
therefore, the functional conservation of the cell
cycle machinery is mirrored in the conserved
way in which these proteins are regulated by
destruction.
Putting Proteolysis to Work
How do cells use proteolysis to control their
growth? One answer to this question has already
been provided: by regulating the proteins that
control cell cycle progression. But a more funda-
mental answer to this question needs to address
exactly how the regulation of these proteins oc-
curs. In other words, what strategies has the cell
devised to harness the power of proteolysis for
growth control? After all of the complexity that
has preceded this point, the reader will be re-
lieved to learn that the answer to this question is
simple: there are just three ways in which Ub-
mediated proteolysis is used to regulate cell
growth. These basic strategies-timed destruc-
tion, continuous destruction, and regulated de-
struction-are at the heart oi all uses of Ub-
mediated proteolysis in the control of cell
growth.
Using Proteolysis I: Timed Destruction
Because Ub-mediated proteolysis can be tightly
regulated, it can bring about protein destruction
at a very specific point during cell cycle progres-
sion. In response to a predetermined signal, Ub-
mediated proteolysis can attack a specific set of
target proteins, causing their levels to drop al-
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Fig. 3. How cells use proteolysis to control
their growth. Three basic strategies for using Ub-
mediated proteolysis are shown. (A) Proteolysis is
used to destroy a protein at a very specific point in
the cell cycle. In this case, timed destruction of the
S-phase inhibitor Siclp allows cells to pass through
the GI-to-S transition. (B) Proteolysis is used to keep
the levels of a regulatory molecule low, and coupled
to its synthesis. In this case, the continuous destruc-
tion of the oncoprotein Myc, coupled with relatively
low rates of transcription of the Myc gene, keeps in-
tracellular levels of Myc at a level compatible with
controlled cell growth. (C) Regulated destruction is
used to induce a rapid change in protein levels in
response to a signal. In this case, DNA damage by
UV light brings about a cessation of p53 destruction,
resulting in a rapid rise in p53 levels and a halt to
cell proliferation. See text for more details.
most instantly. This strategy is used to define
fixed points in the process of cell duplication.
One example of this use of proteolysis, pre-
sented in Figure 3A, is destruction of the yeast
protein Siclp (14). Siclp is a CDK inhibitor that
accumulates during G1 and inhibits the action of
cyclin-CDK complexes required for S-phase ini-
tiation. Toward the end of G1, however, Siclp is
rapidly destroyed via SCF-mediated ubiquityla-
tion. The resulting drop in Siclp levels activates
cyclin-CDK complexes required for S-phase ini-
tiation, and cells are propelled from one phase of
the cell cycle to the next. This use of proteolysis
occurs whenever regulatory proteins must disap-
pear at a precise point: for example, destruction
of the mitotic cyclins (15), which control exit
from mitosis; destruction of Pdslp (16), which
controls sister chromatid segregation; and de-
struction of geminin, which times the onset of
DNA replication (17). The strategy of timed de-
CIn2 unstable
Gic2 stable
Gic2
phosphorylation
Cln2 unstable
Gic2 unstable
Fig. 4. Regulating proteolysis. The figure shows
how Ub-mediated proteolysis can be regulated by
either regulating the activity of the E3 (A) or regu-
lating the susceptibility of the target protein (B). (A)
Activation of the APC during metaphase signals de-
struction of multiple proteins such as Pdslp and the
B cyclins; the coordinated destruction of these pro-
teins is used to drive multiple molecular events re-
quired for exit from mitosis. (B) Differential phos-
phorylation of the GI cyclin Cln2p versus the Cdc42
effector Gic2p differentially affects their destruction
by a common SCF complex: Cln2 is phosphorylated
and unstable throughout G1, while Gic2p is phos-
phorylated, and destroyed, approaching the GI-to-S
transition. See text for details.
struction provides perhaps the most dramatic
demonstration of how proteolysis brings order
and direction to the processes involved in cell
duplication.
Using Proteolysis II: Continuous Destruction
A less spectacular, but nonetheless important,
function of Ub-mediated proteolysis is the con-
tinuous destruction of regulatory proteins. Con-
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tinuous proteolysis is a particularly important
regulatory strategy because it serves to couple
the steady-state levels of a protein to the rate of
its synthesis. If a protein is always destroyed soon
after it is made, it will disappear quickly once
transcription of its gene is shut off. This strategy
is illustrated in Figure 3B.
An interesting example of this use of prote-
olysis is observed with the oncoprotein Myc,
which is a transcription factor that directly acti-
vates the expression of genes required for cell
cycle progression [e.g., cdc25 phosphatase (18)].
Because of this direct link to the cell cycle, high
levels of the Myc protein can drive a cell toward
uncontrolled growth (19). Numerous mecha-
nisms are thus in place to keep levels of the Myc
protein tightly in check. For example, transcrip-
tion of the Myc gene is highly controlled, as is the
stability of Myc mRNA and translation of the
Myc protein (see ref. 20 for details). Capping off
all of this regulation is Ub-mediated proteolysis,
which destroys the Myc protein within minutes
of its production (21). In this scenario, the rapid
destruction of Myc plays a pivotal role in keeping
Myc under control, because it enables the pre-
ceding regulatory processes to exert their influ-
ence over Myc protein levels. This strategy of
continuous destruction is used extensively in
growth control-regulating transcription factors,
GI cyclins (22), and components of the proteo-
lytic machinery [e.g., the APC-activator Cdc2Op
(23)1-as a way to amplify and enforce the ac-
tion of other regulatory mechanisms.
Using Proteolysis III: Regulated Destruction
An important feature of the eukaryotic cell cycle
is that it can react to problems that arise during
the process of cell duplication. If, for example,
there has been a problem with the duplication of
the DNA, cell cycle progression can be delayed
until this problem has been corrected. This reac-
tion of the cell cycle machinery protects the in-
tegrity of the genetic information, by ensuring
that errors in the duplication process are not
passed on to daughter cells. Proteolysis plays an
important role in this response by its ability to
execute rapid, signal-induced changes in the lev-
els of regulatory molecules within the cell. This
process of regulated destruction is the third way
that cells use proteolysis to control their growth.
An interesting example of this kind of regu-
lation, depicted in Figure 3C, involves changes in
the destruction of the tumor suppressor protein
p53 in response to DNA damage (24). p53 is
normally an unstable protein that is turned over
by Ub-mediated proteolysis. Upon exposure of
cells to UV light, however, the destruction of p53
is quickly blocked (25), resulting in a rapid ac-
cumulation of p53, an induction of p53 target
genes, and a block to cell proliferation. Similar
DNA damage and checkpoint-induced changes
in proteolysis have been reported for the CDK
inhibitor p21 (26), the mitotic kinase Weel (27),
and the anaphase inhibitor Pdslp (28). By shut-
ting proteolysis down when there is a problem,
cells thus ensure that they divide only when they
can produce normal, healthy daughters.
Regulating Ubiquitin-Mediated
Proteolysis
A key aspect of protein destruction by Ub-medi-
ated proteolysis is that it can be precisely regu-
lated. Indeed, without such regulation, Ub-medi-
ated proteolysis would not feature so extensively
in the control of cell growth. There are many
ways in which Ub-mediated proteolysis is regu-
lated, but again, these can be reduced to just two
simple principles: regulating the activity of the
ubiquitylating enzyme (E3) or regulating the
susceptibility of the target protein. These two
modes of regulation are illustrated in Figure 4.
Regulating E3 Activity
If two proteins are ubiquitylated by the same E3,
in the absence of any other forms of regulation,
they will be destroyed in the same manner.
When the E3 is inactive, the two proteins will be
stable. When the E3 is active, the two proteins
will be destroyed. This simple scenario illustrates
how cells can coordinately destroy specific
groups of proteins by regulating E3 activity.
A good example of this form of regulation is
the APC, which becomes active late in mitosis.
The activation of the APC promotes coordinate
destruction of many proteins required for exit
from mitosis. For example, Pdslp is ubiquitylated
by a form of the APC containing the regulatory
subunit Cdc2Op (29). As shown in Figure 4A,
Pdslp and APCCdc2O apparently coexist through-
out much of the cell cycle without incident. Ap-
proaching the metaphase-to-anaphase transi-
tion, however, APCCdc2O is activated. The active
APCCdc2O then targets destruction of Pdslp,
which in turn initiates a major event in mitosis-
the segregation of sister chromatids. Importantly,
Pdslp is not the only target of APCCdC20. As
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shown in the figure, the activated APCCdC2O also
targets B-type cyclins (30) for destruction at this
point, triggering other events required for exit
from mitosis. Thus, by regulating APCCdc2O activ-
ity, rather than individually regulating Pdslp and
cyclin B susceptibility, the cell is able to effi-
ciently coordinate multiple molecular events re-
quired for the anaphase-to-metaphase transi-
tion.
Regulating Substrate Susceptibility
If two proteins are ubiquitylated by the same E3,
in the absence of any other forms of regulation,
they will be destroyed in the same manner. If,
however, the susceptibility of one of these pro-
teins to ubiquitylation is differentially regulated,
the two proteins will display very different sta-
bilities. This simple scenario demonstrates how
regulation of substrate susceptibility allows cells
to selectively target a very specific and controlled
subset of proteins for destruction.
The G1 cyclin Cln2p and the Cdc42-effector
Gic2p provide an interesting example of how
substrate regulation allows for differential de-
struction of proteins via a common E3 (Fig. 4B).
An SCF complex, containing the F-box protein
Grrlp, targets the ubiquitylation of both Cln2p
(8) and Gic2p (31). In both cases, substrate rec-
ognition by Grrlp requires phosphorylation of
residues within the Cln2p and Gic2p degrons.
Because these residues in the Cln2p and Gic2p
degrons are differentially phosphorylated, the
two target proteins are destroyed in different
ways: Cln2p is continuously destroyed during
the G1 phase (22), whereas Gic2p accumulates
during G1, but is rapidly destroyed following the
G1-S transition (31). In the case of Cln2p, con-
tinuous destruction serves to link levels of the
Cln2p protein to the rates of Cln2 transcription;
in the case of Gic2p, timed destruction of Gic2p
restricts cytoskeletal polarization to the G1 phase
of the cell cycle. Thus, by regulating individual
substrate susceptibilities, the cell is able to use
the same SCFGrrl complex in different ways and
at different times to drive diverse events required
for cell duplication.
Ubiquitin-Mediated Proteolysis and
Cancer
As discussed throughout this review, Ub-medi-
ated proteolysis regulates many proteins in-
volved in growth control. It seems reasonable to
conclude, therefore, that dysregulation of Ub-
mediated proteolysis might lead to uncontrolled
cell proliferation and perhaps cancer. This is in-
deed the case, and although research in this area
is still in its infancy, we are beginning to under-
stand how changes in protein destruction feature
in oncogenesis.
First, changes in Ub-mediated proteolysis are
important for the action of several viral onco-
proteins. The oncogenic form of Jun, for exam-
ple, carries a deletion that removes much of the
Jun degron (32), making v-Jun more stable than
its cellular counterpart. A similar stabilizing de-
letion has been described for the transcription
factor v-Myb (33). In another example, the hu-
man papillomavirus (HPV16) oncoprotein E6
specifically targets the destruction of the tumor
suppressor protein p53 (34). The E6-mediated
destruction of p53, which defeats the cell's ability
to arrest or die in response to oncogenic pressure,
is an essential part of HPV16's strategy for direct-
ing cellular transformation. Given the uncanny
ability of tumor viruses to select for the most
important and vulnerable regulatory processes, it
seems likely that other, similar examples will be
uncovered in the future.
Second, changes in the Ub-mediated de-
struction of cell cycle regulators have been di-
rectly associated with cancer. The best examples
of this to date are p27 and Myc, which illustrate
how either up-regulation or down-regulation
through Ub-mediated proteolysis can cause
problems. Ub-mediated proteolysis of the CDK
inhibitor p27 is increased in some human can-
cers (35), resulting in a substantial decrease in
steady-state p27 levels. This Ub-mediated de-
crease in p27 levels generally predicts poor pa-
tient survival. Conversely, Ub-mediated destruc-
tion of Myc is down-regulated in some
malignancies; the Myc degron is a hotspot for
mutations in a variety of leukemias and lympho-
mas (36), and several of these mutations have
been shown to subvert the Ub-mediated destruc-
tion of Myc (21), resulting in the production of a
significantly more stable protein with increased
transforming ability. Other examples of sub-
strate-specific defects in proteasomal destruction
will undoubtedly be uncovered in the future.
Finally, there is one example of how muta-
tions in a component of the Ub-proteasome
pathway can feature directly in cancer. The hu-
man tre-2 oncogene encodes a deubiquitylating
enzyme (37) that removes Ub groups from sub-
strate proteins during their destruction by the
proteasome. Because the yeast homolog of this
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gene, DOA4, is required for the efficient destruc-
tion of multiple, but not all, ubiquitylated sub-
strates, it is reasonable to speculate that tre-2 is
oncogenic because it mediates the destruction of
a select group of growth-related proteins in
mammalian cells. These proteins are yet to be
identified. Although this last example is interest-
ing, it seems unlikely that situations like this,
where the proteolytic machinery itself is dereg-
ulated, will feature extensively in cancer. The
involvement of Ub-mediated proteolysis in many
aspects of cellular metabolism may 'protect' the
ubiquitylation machinery from deregulation, be-
cause changes in this machinery might simply
kill cells, rather than offer them a growth advan-
tage. On balance, therefore, it seems much more
probable that substrate-specific changes in pro-
tein destruction, as outlined above, will domi-
nate the arena of Ub-mediated proteolysis and
cancer.
Perspectives
It is clear that Ub-mediated protein destruction
permeates all aspects of cell cycle control in all
eukaryotes. The multifaceted use of this pathway
and its evolutionary success are testaments to the
unique suitability of Ub-mediated proteolysis to
the control of cell growth. In recent years, bio-
chemistry and genetics have come together to
fuel an explosion in our understanding of how
and why proteolysis controls cell growth. But
many questions remain. What is the full extent
of the involvement of the Ub-proteasome path-
way in the control of the cell cycle? Although
many substrates have been identified, it seems
likely that we have only scratched the surface.
We need to identify the complete collection of
target proteins and all the ubiquitylating com-
plexes, and we need to understand how interac-
tions between them are controlled. We also need
to understand the extent of cross-talk between
different ubiquitylation complexes. The potential
for cross-talk is high, given the fact that E3's
often contain common subunits and usually tar-
get multiple proteins for destruction. For exam-
ple, can a protein be stabilized if its E3 is actively
involved in ubiquitylating another protein? Is
this cross-talk used to control cell growth? Fi-
nally, we must understand not only how the
Ub-proteasome pathway functions in cell cycle
control but also how other proteases feature in
this process. There is a small but growing group
of proteases that target cell cycle regulatory pro-
teins-Tsap, for example, which cleaves cyclin A
(38)-and a recently identified complex that can
substitute for the essential functions of the pro-
teasome (for review see ref. 39). We must un-
derstand the role of these proteases and how
they work with Ub-mediated proteolysis to con-
trol cell growth. There is clearly much to be
done: it's degrading work, but someone's got to
do it.
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